Market Overview:
The global fertility drug market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising infertility rates, technological advancements in the field of assisted reproductive technologies (ART), and increasing demand for donor eggs and sperm. The global fertility drug market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into female fertility drugs and male fertility drugs. Female fertility drugs are further sub-segmented into ovulation induction agents, luteinizing hormone (LH) agonists/antagonists, follicle-stimulating hormone (FSH) agonists/antagonists, gonadotropin-releasing hormone analogs (GnRH analogs), progestins for contraception & endometriosis treatment; while male fertility drugs are further sub-segmented into testosterone replacement therapy products & therapies for oligospermia & azoospermia.
Product Definition:
A fertility drug is a medication that is prescribed to improve the chances of getting pregnant. These drugs are used to stimulate ovulation in women who have difficulty conceiving or who have been diagnosed with infertility.
Female:
Female, also known as fertility drug is used by men to impregnate their partners and by women to enhance the quality of eggs for a healthy pregnancy. It's main function is to help the body resume ovulation after having a period.
It can be taken in oral or injectable form and has no age restriction.
Male:
Male is a generic term used for the preparation of medicines. It has two forms, namely testosterone and Androgen (estrogenic) hormone. Testosterone is the male hormone that controls development in males during puberty to adulthood.
Application Insights:
Based on application, the global fertility drug market is segmented into hospitals, clinics and pharmacies. Hospitals held the largest share in 2017 owing to factors such as high patient acceptance of IVF procedures at this setting. Moreover, hospitals have a dedicated team that handles infertility cases and offers advanced treatments including egg freezing and embryo cryopreservation which has resulted in higher adoption of these drugs by infertile couples.
Clinics are expected to witness lucrative growth over the forecast period due to increasing awareness about assisted reproductive technology among both male & female patients as well as their families. Increasing number of adoption for Assisted Hatching (AIH), In Vitro Fertilization (IVF) techniques coupled with rising demand for home ovulation monitoring devices is anticipated to drive demand for these drugs from clinics over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to rise in infertility-related issues and availability of a large number of drugs. In addition, increasing awareness about available treatment options and rising healthcare spending are also driving the regional market growth.
Asia Pacific fertility drug market is anticipated to witness lucrative growth over the forecast period owing to increase in prevalence of target diseases such as diabetes, cancer, & cardiovascular disorders that result in infertility problems. Moreover, growing medical tourism industry will drive demand for fertility drugs leading to an increase demand for ARTs which further drives growth within Asia Pacific region. ‘‘‘‘ ’ â‘’ ✜—¤—¥Ë†…ª¢°' ' ' '' '' '' '.
Growth Factors:
- Increasing awareness about fertility drugs and their benefits is driving the growth of the fertility drug market.
- Rising incidence of infertility is also propelling the growth of the fertility drug market.
- Growing demand for assisted reproductive technologies (ART) is fueling the growth of the fertility drug market.
- increasing number of women opting for single embryo transfer (SET) is contributing to the growth of this market .
Scope Of The Report
Report Attributes
Report Details
Report Title
Fertility Drug Market Research Report
By Type
Female, Male
By Application
Hospitals, Clinics, Drug Store
By Companies
Berlex Laboratories, Baxter, Ferring Pharmaceuticals, Janssen, Pfizer, Takeda, P&G, Roche, Eli Lilly, Merck, Bayer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
145
Number of Tables & Figures
102
Customization Available
Yes, the report can be customized as per your need.
Global Fertility Drug Market Report Segments:
The global Fertility Drug market is segmented on the basis of:
Types
Female, Male
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Berlex Laboratories
- Baxter
- Ferring Pharmaceuticals
- Janssen
- Pfizer
- Takeda
- P&G
- Roche
- Eli Lilly
- Merck
- Bayer
Highlights of The Fertility Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Female
- Male
- By Application:
- Hospitals
- Clinics
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fertility Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fertility drug is a medication used to help couples conceive. It can be prescribed by your doctor to help you become pregnant.
Some of the key players operating in the fertility drug market are Berlex Laboratories, Baxter, Ferring Pharmaceuticals, Janssen, Pfizer, Takeda, P&G, Roche, Eli Lilly, Merck, Bayer.
The fertility drug market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Fertility Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Fertility Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Fertility Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Fertility Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Fertility Drug Market Size & Forecast, 2020-2028
4.5.1 Fertility Drug Market Size and Y-o-Y Growth
4.5.2 Fertility Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Female
5.2.2 Male
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Fertility Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Fertility Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Female
9.6.2 Male
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Female
10.6.2 Male
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Female
11.6.2 Male
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Female
12.6.2 Male
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Female
13.6.2 Male
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Fertility Drug Market: Competitive Dashboard
14.2 Global Fertility Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Berlex Laboratories
14.3.2 Baxter
14.3.3 Ferring Pharmaceuticals
14.3.4 Janssen
14.3.5 Pfizer
14.3.6 Takeda
14.3.7 P&G
14.3.8 Roche
14.3.9 Eli Lilly
14.3.10 Merck
14.3.11 Bayer
